Cytotherapy

Labeling and tracking of mesenchymal stromal cells with EdU.

Cytotherapy

Lin G, Huang YC, Shindel AW, Banie L, Wang G, Lue TF, Lin CS

Treatment of stress urinary incontinence with adipose tissue-derived stem cells.

Cytotherapy

Lin G, Wang G, Banie L, Ning H, Shindel AW, Fandel TM, Lue TF, Lin CS

Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes.

Cytotherapy

Gaur M, Ritner C, Sievers R, Pedersen A, Prasad M, Bernstein HS, Yeghiazarians Y

Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition.

Cytotherapy

Yeghiazarians Y, Gaur M, Zhang Y, Sievers RE, Ritner C, Prasad M, Boyle A, Bernstein HS

Identification of active and quiescent adipose vascular stromal cells.

Cytotherapy

Lin G, Xin Z, Zhang H, Banie L, Wang G, Qiu X, Ning H, Lue TF, Lin CS

Is CD34 truly a negative marker for mesenchymal stromal cells?

Cytotherapy

Lin CS, Ning H, Lin G, Lue TF

Effects of EdU labeling on mesenchymal stem cells.

Cytotherapy

Ning H, Albersen M, Lin G, Lue TF, Lin CS

Accelerating the development of innovative cellular therapy products for the treatment of cancer.

Cytotherapy

Stewart MD, Keane A, Butterfield LH, Levine BL, Thompson B, Xu Y, Ramsborg C, Lee A, Kalos M, Koerner C, Moore T, Markovic I, Lasiter L, Ibrahim R, Bluestone J, Sigal E, Allen J

Fludarabine-exposure predicts disease control following CD19-specific car t cell (tisagenlecleucel); a report from pediatric real-world car consortium.

Cytotherapy

K.J. Curran, V.A. Fabrizio, A. Mauguen, J.J. Boelens, C. Baggott, S. Prabhu, H. Placenta, C.L. Phillips, J. Rossoff, H. Stefanski, J. Talano, A. Moskop, S.P. Margossian, M.R. Verneris, G. Myers, N.A. Karras, P.A. Brown, M. Qayed, M. Hermiston, P. Satwani, C. Krupski, A. Keating, R. Wilcox, C.A. Rabik, V. Chinnabhandar, M. Kunicki, A. Goksenin, C. Mackall, T.W. Laetsch, L.M. Schultz

Pages